Status:
COMPLETED
Reduced COPD Related Utilization of Healthcare Services and Increased Social Activities by Patients Offered a 24/7 Accessible Telehealth Service Based on the Epital Care Model.
Lead Sponsor:
ECM Klinikken APS
Conditions:
COPD (Chronic Obstructive Pulmonary Disease)
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
The purpose of this study (The TEMOKAP study) is to investigate whether home-based treatment with telemedicine and support from healthcare professionals can prevent acute exacerbations of COPD and avo...
Detailed Description
Why the TEMOKAP Study? The TEMOKAP study represents a new treatment method where, with the help of modern technology and telemedicine, we can offer examination and treatment in your own home if a medi...
Eligibility Criteria
Inclusion
- aged ≥ 45 years
- diagnosed with COPD according to the criteria of the GOLD guideline
- a score of minimum three out of six points in cognitive screening test (The Clock Test + Three-Word Recall Memory Test)
- must have the ability to provide oral or written informed consent
- must have access to the internet in their own home
- must own a smartphone
- must be able to use simple functions in web browsers.
Exclusion
- unstable heart disease
- poorly regulated diabetes
- diagnosed with psychiatric conditions who leads to mental impaired functions
- unable to communicate in oral and written Danish.
Key Trial Info
Start Date :
September 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 2 2022
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT06988566
Start Date
September 4 2020
End Date
September 2 2022
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The ECM Clinic
Søborg, Denmark, 2860